Microbiome in human immunodeficiency virus infection

Clinics in Laboratory Medicine

Volumn 34, Issue 4, 2014, Pages 733-745

  Salas, January T ^a   Chang, Theresa L ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

HIV pathogenesis; HIV transmission; Immune activation; Microbial translocation; Microbiome

Indexed keywords

CERVICAL MICROBIOME; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INTESTINE FLORA; LUNG MICROFLORA; MICROBIOME; MOUTH FLORA; NONHUMAN; PENILE MICROBIOME; PERIODONTAL MICROBIOME; PRIORITY JOURNAL; RECTAL MICROBIOME; REVIEW; VAGINA FLORA; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; FEMALE; LUNG; MALE; MICROBIOLOGY; MICROFLORA; MOUTH; PATHOLOGY; PENIS; RECTUM; TRANSMISSION; UTERINE CERVIX; VAGINA; VIROLOGY;

CERVIX UTERI; FEMALE; HIV INFECTIONS; HUMANS; LUNG; MALE; MICROBIOTA; MOUTH; PENIS; RECTUM; VAGINA;

EID: 84923860698     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2014.08.005     Document Type: Review

References (93)

1. Atashili J., Poole C., Ndumbe P.M., et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008, 22(12):1493-1501.
2. Shulzhenko N., Morgun A., Hsiao W., et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011, 17(12):1585-1593.
3. Petrova M.I., van den Broek M., Balzarini J., et al. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev 2013, 37(5):762-792.
4. Lozupone C., Cota-Gomez A., Palmer B.E., et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 2013, 187(10):1110-1117.
5. Klatt N.R., Canary L.A., Sun X., et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. JClin Invest 2013, 123(2):903-907.
6. Anderson D., Politch J.A., Pudney J. HIV infection and immune defense of the penis. Am J Reprod Immunol 2011, 65(3):220-229.
7. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9(5):313-323.
8. Zelante T., Iannitti R.G., Cunha C., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39(2):372-385.
9. Favre D., Mold J., Hunt P.W., et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010, 2(32):32ra36.
10. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature 2012, 486(7402):207-214.
11. Cohen C.R., Lingappa J.R., Baeten J.M., et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012, 9(6):e1001251.
12. Dillon S.M., Lee E.J., Kotter C.V., et al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol 2014, 7(4):983-994.
13. Doerflinger S.Y., Throop A.L., Herbst-Kralovetz M.M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. JInfect Dis 2014, 209(12):1989-1999.
14. McHardy I.H., Li X., Tong M., et al. HIV Infection is associated with compositionaland functional shifts in the rectal mucosal microbiota. Microbiome 2013, 1(1):26.
15. Sturm-Ramirez K., Gaye-Diallo A., Eisen G., et al. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. JInfect Dis 2000, 182(2):467-473.
16. Martin H.L., Richardson B.A., Nyange P.M., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. JInfect Dis 1999, 180(6):1863-1868.
17. Frank D.N., Manigart O., Leroy V., et al. Altered vaginal microbiota are associated with perinatal mother-to-child transmission of HIV in African women from Burkina Faso. JAcquir Immune Defic Syndr 2012, 60(3):299-306.
18. Brenchley J.M., Price D.A., Schacker T.W., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12(12):1365-1371.
19. Hunt P.W. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012, 9(2):139-147.
20. Guaraldi G., Orlando G., Zona S., et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011, 53(11):1120-1126.
21. Marchetti G., Tincati C., Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013, 26(1):2-18.
22. Hazenberg M.D., Stuart J.W., Otto S.A., et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000, 95(1):249-255.
23. Neuhaus J., Jacobs D.R., Baker J.V., et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. JInfect Dis 2010, 201(12):1788-1795.
24. Brenchley J.M., Silvestri G., Douek D.C. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010, 32(6):737-742.
25. Jacquelin B., Mayau V., Targat B., et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. JClin Invest 2009, 119(12):3544-3555.
26. Silvestri G., Sodora D.L., Koup R.A., et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003, 18(3):441-452.
27. Lim S.G., Condez A., Lee C.A., et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993, 92(3):448-454.
28. Aas J.A., Barbuto S.M., Alpagot T., et al. Subgingival plaque microbiota in HIV positive patients. JClin Periodontol 2007, 34(3):189-195.
29. Veazey R.S., DeMaria M., Chalifoux L.V., et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280(5362):427-431.
30. Brenchley J.M., Schacker T.W., Ruff L.E., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. JExp Med 2004, 200(6):749-759.
31. Blaschitz C., Raffatellu M. Th17 cytokines and the gut mucosal barrier. JClin Immunol 2010, 30(2):196-203.
32. Raffatellu M., Santos R.L., Verhoeven D.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008, 14(4):421-428.
33. Brenchley J.M., Paiardini M., Knox K.S., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112(7):2826-2835.
34. Petrovas C., Casazza J.P., Brenchley J.M., et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. JExp Med 2006, 203(10):2281-2292.
35. Kristoff J., Haret-Richter G., Ma D., et al. Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication. JClin Invest 2014, 124(6):2802-2806.
36. Rose W.A., McGowin C.L., Spagnuolo R.A., et al. Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS One 2012, 7(3):e32728.
37. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010, 10(10):735-744.
38. Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin Vaccine Immunol 2006, 13(2):219-226.
39. Ivanov I.I., Atarashi K., Manel N., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139(3):485-498.
40. Kau A.L., Ahern P.P., Griffin N.W., et al. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474(7351):327-336.
41. Saxena D., Li Y., Yang L., et al. Human microbiome and HIV/AIDS. Curr HIV/AIDS Rep 2012, 9(1):44-51.
42. Gori A., Tincati C., Rizzardini G., et al. Early impairment of gut function and gutflora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. JClin Microbiol 2008, 46(2):757-758.
43. Saavedra J.M., Bauman N.A., Oung I., et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994, 344(8929):1046-1049.
44. Hummelen R., Changalucha J., Butamanya N.L., et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2011, 2(2):80-85.
45. Pyles R.B., Vincent K.L., Baum M.M., et al. Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures. PLoS One 2014, 9(3):e93419.
46. Furusawa Y., Obata Y., Fukuda S., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504(7480):446-450.
47. Vujkovic-Cvijin I., Dunham R.M., Iwai S., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013, 5(193):193ra191.
48. Dang A.T., Cotton S., Sankaran-Walters S., et al. Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients. BMC Microbiol 2012, 12:153.
49. Ryder M.I. Periodontal management of HIV-infected patients. Periodontol 2000 2000, 23:85-93.
50. Pereira V.T., Pavan P., Souza R.C., et al. The association between detectable plasmatic human immunodeficiency virus (HIV) viral load and different subgingival microorganisms in Brazilian adults with HIV: a multilevel analysis. JPeriodontol 2014, 85(5):697-705.
51. Silva-Boghossian C., Castro G.F., Teles R.P., et al. Salivary microbiota of HIV-positive children and its correlation with HIV status, oral diseases, and total secretory IgA. Int J Paediatr Dent 2008, 18(3):205-216.
52. Ocon S., Murphy C., Dang A.T., et al. Transcription profiling reveals potential mechanisms of dysbiosis in the oral microbiome of rhesus macaques with chronic untreated SIV infection. PLoS One 2013, 8(11):e80863.
53. Mataftsi M., Skoura L., Sakellari D. HIV infection and periodontal diseases: an overview of the post-HAART era. Oral Dis 2011, 17(1):13-25.
54. Imai K., Ochiai K., Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. JImmunol 2009, 182(6):3688-3695.
55. Greenspan D., Gange S.J., Phelan J.A., et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. JDent Res 2004, 83(2):145-150.
56. George M.D., Verhoeven D., Sankaran S., et al. Heightened cytotoxic responses and impaired biogenesis contribute to early pathogenesis in the oral mucosa of simian immunodeficiency virus-infected rhesus macaques. Clin Vaccine Immunol 2009, 16(2):277-281.
57. Aas J.A., Paster B.J., Stokes L.N., et al. Defining the normal bacterial flora of the oral cavity. JClin Microbiol 2005, 43(11):5721-5732.
58. Kotler D.P., Gaetz H.P., Lange M., et al. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984, 101(4):421-428.
59. Moeller A.H., Shilts M., Li Y., et al. SIV-induced instability of the chimpanzee gut microbiome. Cell Host Microbe 2013, 14(3):340-345.
60. Mutlu E.A., Keshavarzian A., Losurdo J., et al. Acompositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 2014, 10(2):e1003829.
61. Merlini E., Bai F., Bellistri G.M., et al. Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One 2011, 6(4):e18580.
62. Ahmed N., Hayashi T., Hasegawa A., et al. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. JGen Virol 2010, 91(Pt 11):2804-2813.
63. Perez-Santiago J., Gianella S., Massanella M., et al. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS 2013, 27(12):1921-1931.
64. Dandekar S., George M.D., Baumler A.J. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010, 5(2):173-178.
65. Smith P.M., Garrett W.S. The gut microbiota and mucosal T cells. Front Microbiol 2011, 2:111.
66. Kim M., Ashida H., Ogawa M., et al. Bacterial interactions with the host epithelium. Cell Host Microbe 2010, 8(1):20-35.
67. Yu G., Fadrosh D., Ma B., et al. Anal microbiota profiles in HIV-positive and HIV-negative MSM. AIDS 2014, 28(5):753-760.
68. McCoy A.N., Araujo-Perez F., Azcarate-Peril A., et al. Fusobacterium is associated with colorectal adenomas. PLoS One 2013, 8(1):e53653.
69. Ohkusa T., Okayasu I., Ogihara T., et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 2003, 52(1):79-83.
70. Shirakawa K., Chavez L., Hakre S., et al. Reactivation of latent HIV by histone deacetylase inhibitors. Trends Microbiol 2013, 21(6):277-285.
71. Victoriano A.F., Imai K., Okamoto T. Interaction between endogenous bacterial flora and latent HIV infection. Clin Vaccine Immunol 2013, 20(6):773-779.
72. Hummelen R., Fernandes A.D., Macklaim J.M., et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010, 5(8):e12078.
73. Spear G.T., Gilbert D., Sikaroodi M., et al. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses 2010, 26(2):193-200.
74. Spear G.T., Sikaroodi M., Zariffard M.R., et al. Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. JInfect Dis 2008, 198(8):1131-1140.
75. Schellenberg J.J., Plummer F.A. The microbiological context of HIV resistance: vaginal microbiota and mucosal inflammation at the viral point of entry. Int J Inflam 2012, 2012:131243.
76. Gajer P., Brotman R.M., Bai G., et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 2012, 4(132):132ra152.
77. Ravel J., Gajer P., Abdo Z., et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2011, 108(Suppl 1):4680-4687.
78. Klebanoff S.J., Coombs R.W. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. JExp Med 1991, 174(1):289-292.
79. Bebell L.M., Passmore J.A., Williamson C., et al. Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. JInfect Dis 2008, 198(5):710-714.
80. Beigi R.H., Yudin M.H., Cosentino L., et al. Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. JInfect Dis 2007, 196(9):1355-1360.
81. Mitchell C., Hitti J., Paul K., et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses 2011, 27(1):35-39.
82. Auvert B., Taljaard D., Lagarde E., et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2(11):e298.
83. Price L.B., Liu C.M., Johnson K.E., et al. The effects of circumcision on the penis microbiome. PLoS One 2010, 5(1):e8422.
84. Johnson K.E., Sherman M.E., Ssempiija V., et al. Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS 2009, 23(14):1807-1815.
85. Liu C.M., Hungate B.A., Tobian A.A., et al. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. MBio 2013, 4(2):e00076.
86. Schneider J.A., Vadivelu S., Liao C., et al. Increased likelihood of bacterial pathogens in the coronal sulcus and urethra of uncircumcised men in a diverse group of HIV infected and uninfected patients in India. JGlob Infect Dis 2012, 4(1):6-9.
87. Corey L., Wald A., Celum C.L., et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. JAcquir Immune Defic Syndr 2004, 35(5):435-445.
88. Weiss H.A., Thomas S.L., Munabi S.K., et al. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 2006, 82(2):101-109. [discussion: 110].
89. Segal L.N., Methe B.A., Nolan A., et al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 2011, 8(3):282-287.
90. Iwai S., Fei M., Huang D., et al. Oral and airway microbiota in HIV-infected pneumonia patients. JClin Microbiol 2012, 50(9):2995-3002.
91. Iwai S., Huang D., Fong S., et al. The lung microbiome of Ugandan HIV-infected pneumonia patients is compositionally and functionally distinct from that of San Franciscan patients. PLoS One 2014, 9(4):e95726.
92. Cribbs S.K., Park Y., Guidot D.M., et al. Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls. AIDS Res Hum Retroviruses 2014, 30(6):579-585.
93. Beck J.M., Young V.B., Huffnagle G.B. The microbiome of the lung. Transl Res 2012, 160(4):258-266.